Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Change in Accured Expenses (2020 - 2025)

Rapid Micro Biosystems' Change in Accured Expenses history spans 6 years, with the latest figure at $1.1 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 349.89% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28000.0, a 100.72% increase, with the full-year FY2025 number at $28000.0, up 100.72% from a year prior.
  • Change in Accured Expenses hit $1.1 million in Q4 2025 for Rapid Micro Biosystems, up from $599000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for RPID hit a ceiling of $2.9 million in Q4 2023 and a floor of -$3.9 million in Q1 2022.
  • Historically, Change in Accured Expenses has averaged -$144150.0 across 5 years, with a median of -$165500.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 396.8% in 2022 and later soared 28860.0% in 2023.
  • Tracing RPID's Change in Accured Expenses over 5 years: stood at -$341000.0 in 2021, then skyrocketed by 102.93% to $10000.0 in 2022, then soared by 28860.0% to $2.9 million in 2023, then tumbled by 115.16% to -$439000.0 in 2024, then soared by 349.89% to $1.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for RPID at $1.1 million in Q4 2025, $599000.0 in Q3 2025, and $335000.0 in Q2 2025.